Nanexa AB (OSTO:NANEXA) 3-Year EBITDA Growth Rate : 32.40% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Nanexa AB 3-Year EBITDA Growth Rate?

Nanexa AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 32.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Nanexa AB was 32.40% per year. The lowest was -15.40% per year. And the median was -2.55% per year.

Competitive Comparison of Nanexa AB's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Nanexa AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanexa AB's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nanexa AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Nanexa AB's 3-Year EBITDA Growth Rate falls into.

Nanexa AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Nanexa AB (OSTO:NANEXA) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Nanexa AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Nanexa AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanexa AB (OSTO:NANEXA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanexa AB (OSTO:NANEXA) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Virdings Alle 32B, Uppsala, SWE, 75450

Website

https://www.nanexa.com

Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary and innovative drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its own products and also has collaboration agreements with several pharma companies, among others AstraZeneca.

Nanexa AB (OSTO:NANEXA) Headlines

No Headlines